The DVB has approved the commercial requirements for version 1.4 of the CI Plus specification. Separately the DVB has formed a partnership with the 3D@Home Consortium to encourage the development of standards for 3D TV and to share knowledge.The commercial requirements for CI Plus version 1.4 build on the current version 1.3 of CI Plus by adding support for dual-stream operation with a single module – meaning that a dual-tuner DVR host can be supported – as well as support for DRM-protected IP delivered content. Other features include CI Plus browser extensions, additional uniform resource identifiers, signaling and extensions and clarifications for module applications running on host middleware.The move follows an agreement with CI Plus LLP that DVB will take responsibility for future development of the CI Plus specification. It is anticipated that the technical work will take a year. Following its publication CI Plus LLP will adopt the specification.The DVB has also formed a partnership with the 3D@Home Consortium. The consortium was formed in 2008 with the mission to speed the commercialisation of 3D and provide the best possible viewing experience by facilitating the development of standards. In February 2011, the DVB Steering Board approved the specification for a first phase 3DTV delivery system based on the commonly used ‘frame-compatible’ system.“3D@Home is an important organisation for 3DTV. They have many areas of interest, including the study of ‘human factors’ associated with 3DTV viewing that we are hoping to learn from. For our part, our work developing delivery specifications for 3DTV, will be helpful for 3D@home. Both organizations have things to share with each other,” said David Wood, chair of DVB’s Commercial Module on 3DTV.
Music network Vintage TV has launched on Virgin Media’s cable platform in the UK. The channel went live on the platform yesterday at number 343 on the EPG and is available to subscribers of Virgin’s premium XL channel package – which includes more than 200 channels and 30 HD stations.Vintage TV airs a range of original music programming, classic concert footage, and interviews and documentaries. It also airs on the Sky and Freesat platforms in the UK and says it plans to launch on more shortly.Vintage TV is broadcast from the UK, on Eurobird 1 at 28.8 degrees East on transponder C2 Lower.
Irish telco, Eircom, said that its TV service continued to gain traction in the quarter ending March 31 with 37,000 TV customers, representing 26% of its consumer fibre base. Announcing results for its fiscal third quarter, the operator said that 22% of customers now have TV/mobile bundles and that the rollout of its next generation access network continues at pace.“Our network has now passed 1.2 million homes and businesses, representing more than 50% of all premises in Ireland,” said Eircom group CEO Richard Moat.Last year, Eircom set a June 2014 target of 24,000 customers for its then recently-launched eVision IPTV service.Overall in its latest quarter, the company reported revenues of €311 million, down 1% year-on-year. EBITDA was €120 million, an increase of 8% year-on-year.
Doug spoke in trenchant munificent stentorian and intelligent terms—everyone should read and ponder what he spoke so eloquently about.—Anonymous Recommended Link In Case You Missed It… Our colleague Teeka Tiwari is a crypto investing expert. He’s very bullish on the sector and has helped his subscribers score gains of up to 20,000%. This Thursday, Teeka is hosting a free cryptocurrency training seminar. Reserve your spot right here. Recommended Link I read your email, and it disturbed me far more than the subject itself. To lump all protestors together as being created by someone else’s agenda rather than thoughtful humans concerned about an injustice saddened me. But it did get me to look into the story more. I found a very thoughtful article you might find interesting. —Amy But don’t just take my word for it. Look at what Phyto Partners is doing… Phyto Partners is a venture capital fund that invests in early-stage cannabis companies. Today, it has 12 companies in its portfolio. And none of them grow, process, or sell marijuana. Instead, they serve the marijuana industry.One of those companies, New Frontier Data, is a major marijuana data firm. Another, Steep Hill Labs, is a leader in marijuana lab testing. Then there’s Grownetics…• This company is radically changing how people grow marijuana… I know because I recently visited the Grownetics team in downtown Boulder, Colorado. In a minute, I’ll tell you how Grownetics is revolutionizing the marijuana industry. I’ll also tell you about the incredible insight I learned while in Boulder. But let me first tell you what I was doing there. After all, Boulder’s a long way from Casey Research’s headquarters in Florida.• In June, I did something I’ve wanted to do for years… I turned in my apartment key. I sold most of my belongings. And I hit the road. That’s right. I left sunny South Florida to become a digital nomad. I did this because I’ve come to realize something working with Doug Casey… The best money-making opportunities are rarely in plain sight. More often than not, they’re hidden. This means you need to go “into the field” to find them. That’s particularly true for the legal marijuana market, which is being born before our eyes.• So I went to the frontlines of this emerging industry… My first stop was Vancouver. I spent all of July there. After that, I went to San Francisco for three weeks. Then, I spent nearly all of September in Colorado. There, I visited an indoor marijuana growing facility. I toured a state-of-the-art cannabis research lab. And yes, I drove to Boulder to meet the Grownetics team. I did this because an industry insider told me that Grownetics is doing incredible work. And he wasn’t joking… 3 Marijuana Stocks to Buy Right Now Canada is set to vote on a new nationwide law that will set off the biggest event in the history of marijuana. The Canadian pot market will explode from $400 million to $8 billion. And new marijuana millionaires will be minted. If you missed out on the first marijuana boom, when penny pot stocks delivered peak gains of 7,820%… 6,233%… and 3,986%… often in months… This is your second and final chance. Don’t miss out again. Discover the 3 companies that will dominate the marijuana market. — Teeka’s new cryptocurrency prediction will shock you Teeka’s previous cryptocurrency predictions could have made you 1,241%, 2,050% and even 14,354% in as little as 6 months. To get his latest prediction – including the name of the crypto he calls “the next big thing in cryptocurrencies” – click here. By Justin Spittler, editor, Casey Daily Dispatch Big money is pouring into marijuana. During the first four months of 2017, cannabis-related companies raised more than $700 million. That’s almost seven times more than they raised during the same period last year. This isn’t “dumb money,” either. Some of the world’s savviest investors have placed huge bets on marijuana. Peter Thiel, for example, recently invested millions of dollars in Privateer Holdings, a private equity firm focused on legal cannabis. Thiel was an early investor in Facebook, and is a legend in Silicon Valley. Then there’s venture capital firm Benchmark Capital, which was an early investor in Twitter, Uber, Snapchat, and Instagram. It recently put $8 million in Hound Labs, an Oakland-based startup that’s developing a device to test whether drivers are under the influence of marijuana. These are big investments from big-time investors.• It tells us the marijuana boom is for real… And that’s exactly why you should consider speculating on marijuana stocks if you haven’t already. But you should realize something before diving in… The best marijuana investments aren’t traditional marijuana companies. They’re companies that serve the industry. • You see, Grownetics isn’t your typical marijuana company… It doesn’t grow marijuana. It doesn’t own dispensaries. And it doesn’t make marijuana edibles. Instead, it’s a technology company that’s solving one of the marijuana industry’s biggest problems. You see, most marijuana companies have a “head of cultivation” on staff. This person feeds, waters, and monitors the health of marijuana plants at an indoor facility. Over time, they figure out what the plants like and what they don’t like. And many head cultivators simply write this information down in a journal. This approach isn’t just old-fashioned. It’s risky. Think about it. If the head of cultivation walks, they’re going to take that information with them. And that basically screws over the owner of the facility.• Grownetics wants to fix this problem with technology… And here’s how… Grownetics builds operating systems for indoor farmers and greenhouse cultivators. This system includes management software linked to a network of high-resolution sensors inside marijuana growing facilities. These sensors monitor room temperature, lighting, humidity, CO2 levels, and a host of other inputs. Grownetics’ software then organizes this data in a way that’s easy to understand. This saves companies time and money. And it helps them boost the yield and potency of their crop. (You can learn more about the incredible work that Vince and his team are doing by visiting their website right here.) In short, Grownetics helps companies grow better pot, and a lot more of it. That’s why the company has customers all over the country, and a rapidly growing pipeline…• But I know what you’re probably thinking… “Marijuana’s a weed. How hard can it possibly be to grow?” Well, actually, it can be very difficult. That’s because marijuana’s a very complex plant. In fact, Grownetics COO Vince Harkiewicz told me there’s “never been a pharmaceutical crop like marijuana”: The closest thing might be poppies, which are used to make opiates for pharmaceutical industries, but that’s just one chemical you’re producing. With cannabis, there’s hundreds of cannabinoids and terpenes in the plant. And they all affect the way the medicine is received by the patient. That’s right. • Marijuana isn’t just a plant that gets people high… It’s also medicine. That’s why the world’s top botanists are coming to the marijuana industry in droves. It’s why the world’s best investors are pouring billions into marijuana companies. It’s also why companies are paying top dollar for Grownetics’ services.• Now, I unfortunately can’t recommend Grownetics to you… The company’s private, and a startup at that. So, why did I tell this story? Simple. Most people have ridiculous misconceptions about the marijuana industry. They think the industry’s run by stoners, hippies, and burnouts. But that couldn’t be further from the truth. The industry’s attracting world-class entrepreneurs, engineers, and scientists. It’s employing real science. And it’s developing its own cutting-edge technology. In short, the legal marijuana industry is becoming more and more like Big Pharma every day.• Soon, everyday investors will figure this out… When that happens, money will pour into marijuana stocks like we’ve never seen. That’s something you want to be ready for. So, consider buying marijuana stocks if you haven’t already. Just understand that these stocks are still very speculative. So, do your homework before diving in. I also encourage you to read these recent articles of mine: Why This U.S. Army Officer Retired to Focus on Cannabis The Great Marijuana Bull Market Has Officially Arrived The Window’s Closing…But You Can Still Become a “Marijuana Millionaire” The No. 1 Mistake Marijuana Investors Are Making As you’ll see, the biggest opportunities in marijuana aren’t in the States. They’re north of the border in Canada…Regards,Justin Spittler New Orleans, LA October 31, 2017 P.S. This marijuana boom is just getting started. And now is the time to own the best stocks to take advantage. We have a basket of marijuana companies in our Crisis Investing newsletter that are set to soar in the coming years. You can access these names, along with all of our research on the sector, with a subscription to Crisis Investing. Click here to learn more. Sights From the Road Earlier, I told you how I left sunny South Florida to become a traveling analyst. So far, my world tour has taken me to Vancouver, Seattle, San Francisco, Denver, Las Vegas, South Carolina, and New Orleans. Along the way, I’ve seen some incredible things. So today, I’m going to share a few photographs that I took at Grownetics’ headquarters in downtown Boulder. The first photo shows the workstation in Grownetics’ lab. Next, a 3D printing machine that Vince and his team use to make components. Finally, here’s a photo of an award that Grownetics picked up last year at the 2016 Cannabist Awards in Las Vegas for Best Technology Start-up. As you can see, Vince and the rest of the Grownetics team are doing some incredible things. So, be sure to check out their website to learn more about them.Reader MailbagToday, readers write in with their thoughts on Doug Casey’s interview on cultural appropriation:Doug—you are right on the money, as usual. The SJW mentality is a step towards control, and the type of control they desire is evident from those who have done this before.—Barry —
The new school year started off in brand-new buildings for two elementary schools in the Tuscaloosa City Schools System.Arcadia and Oakdale elementaries opened their doors for students today, along with the rest of the Tuscaloosa City Schools System, but these schools were home to their very first classes.Arcadia Elementary Principal Amy Elam said she was so excited that she could watch her students enjoy their first day back in a brand new building.“We are so thrilled and thankful to be able to walk into this state-of-the-art building,” Elman said. “As we begin classes this morning the teachers are just anxiously awaiting the students and this new school year.”Over at Oakdale, students got the red carpet treatment.“Our students are the best and they deserve the best,” Daria said. “So that’s what they are getting the red carpet treatment as they get welcomed into their new building this morning. ”Daria said the new Skyland Elementary School is opening later this year.
Bloodwork was supposed to be the last step in Isela’s application for life insurance. But when she arrived at the lab, her appointment had been canceled.”That was my first warning,” Isela says. She contacted her insurance agent and was told her application was denied because something on her medication list indicated that Isela uses drugs. Isela, a registered nurse who works in an addiction treatment program at Boston Medical Center, scanned her med list. It showed a prescription for the opioid-reversal drug naloxone — brand name Narcan.”But I’m a nurse, I use it to help people,” Isela remembers telling her agent. “If there is an overdose, I could save their life.”That’s a message public health leaders aim to spread far and wide. “BE PREPARED. GET NALOXONE. SAVE A LIFE,” was the message at the top of a summary advisory from the U.S. surgeon general in April.But some life insurers consider the use of prescription drugs when reviewing policy applicants. And it can be difficult, some say, to tell the difference between someone who carries naloxone to save others and someone who carries naloxone because they are at risk for an overdose.Primerica is the insurer Isela says turned her down. (NPR has agreed to use just Isela’s first name because she is worried about how this story might affect her ongoing ability to get life insurance.) The company says it can’t discuss individual cases. But in a prepared statement, Primerica notes that naloxone has become increasingly available over the counter.”Now, if a life insurance applicant has a prescription for naloxone, we request more information about its intended use as part of our underwriting process,” says Keith Hancock, the vice president for corporate communications. “Primerica is supportive of efforts to help turn the tide on the national opioid epidemic.”After Primerica turned her down, Isela applied to a second life insurer and was again denied coverage. But the second company told her it might reconsider if she obtained a letter from her doctor explaining why she needs naloxone. So, Isela did contact her primary care physician — and then realized that her doctor had not prescribed the drug.Isela had bought naloxone at a pharmacy. To help reduce overdose deaths, Massachusetts and many other states have established a standing order for naloxone — one prescription that works for everybody. Isela couldn’t just give her insurer that statewide prescription; she had to find the doctor who signed it. As it happens, that physician — Dr. Alex Walley — also works at Boston Medical Center.Walley is an associate professor of medicine at Boston University; he also works in addiction medicine at Boston Medical Center and is the medical director for the Opioid Overdose Prevention Pilot Program at the Massachusetts Department of Public Health.”We want naloxone to be available to a wide group of people — people who have an opioid use disorder themselves, but also [those in] their social networks and other people in a position to rescue them,” Walley says.He says he’s written a half dozen letters for other BMC employees denied life or disability insurance because of naloxone, and that troubles him.”My biggest concern is that people will be discouraged by this from going to get a naloxone rescue kit at the pharmacy,” Walley says. “So this has been frustrating.”The life insurance hassle — and threat of being turned to down — has discouraged Isela and some of her fellow nurses. She is not carrying a naloxone kit outside the hospital right now because she doesn’t want it to show up on her active medication list until the life insurance problem is sorted out.”So if something were to happen on the street, I don’t have one — just because I didn’t want another conflict,” Isela said.BMC has alerted the state’s Division of Insurance, which has said in a written response that it is reviewing the cases and drafting guidelines for “the reasonable use of drug history information in determining whether to issue a life insurance policy.”But Isela isn’t a drug user. And yet, she is being penalized as if she were.Michael Botticelli, who runs the Grayken Center for Addiction Medicine at BMC, says friends and family members of patients with an addiction must be able to carry naloxone without fear that doing so will send them to the insurance reject pile.”It’s incumbent on all of us to make sure that we try to kind of nip this in the bud,” he says, “before it is any more wide-scale.”Botticelli says increased access to naloxone across Massachusetts is one of the main reasons overdose deaths are down in the state. The most recent state report shows 20 fewer fatalities this year compared to last.Botticelli relayed his concerns in a letter to Dr. Jerome Adams, the U.S. surgeon general, who says he contacted the National Association of Insurance Commissioners. That group says it has not heard of any cases of life insurance applicants being denied because they purchased naloxone.Adams says it’s good to, as Botticelli suggests, nip the problem in the bud.”Naloxone saves lives,” Adams says, “and it is important that all Americans know about the vital role bystanders can play in preventing opioid overdose deaths when equipped with this lifesaving medication.”Isela says the second company that rejected her has agreed to let her reapply, in light of Walley’s letter stating that she carries the drug so that she can reverse an overdose. Isela is in the process of reapplying.This story is part of a reporting partnership with NPR, WBUR and Kaiser Health News. Copyright 2018 WBUR. To see more, visit WBUR.
Get 1 Year of Green Entrepreneur for $19.99 Cannabis Journalist | Tech Evangelist Covering High Growth Trends 8 min read Next Article Image credit: Kevork Djansezian | Getty Images Add to Queue Guest Writer Andre Bourque Green Entrepreneur provides how-to guides, ideas and expert insights for entrepreneurs looking to start and grow a cannabis business. People growing their own marijuana is a significant concern to Big Pharma. As state legalization of cannabis-derivatives spreads, the drug companies contemplating the potential of medical marijuana see a threat from both homegrown and professionally harvested medical-grade marijuana.Pharma offers quality control and deep testing but experience shows that research and development adds to customer cost. Even the 21st Century Cures Act won’t speed up the famously slow pace of FDA drug approvals. Given the facts and the perception, you have to wonder if Big Pharma is for or against legalizing marijuana.Related: Science and FDA Say Cannabis Is Medicine but DEA Insists It Isn’tHere’s the problem.A lot of money always attracts a lot interest. Big Pharma wants the revenues that marijuana promises but concede market forces threaten their interests. Big Pharma can’t getting its biggest slice of the pie with individuals and licensed producers harvesting cannabis, not to mention the the black market that continues to thrive.Ben Cohen, writing for US News, insists it’s all about money. He writes, “For years, large corporations and well-heeled lobbyists have blocked the legalization of marijuana for medical use or recreational use in order to protect their own profits.”There’s no reason to expect this to stop.On the other hand, cannabis advocates have a personal and emotional investment in promoting the legalization, or at least decriminalization, of marijuana. Sometimes that makes them anti-institutional and they skew the role of Big Pharma. Finding an objective point of view is difficult.You might consider the hypocrisy at the February 2014 meeting of the Community Anti-Drug Coalition of America (CADCA). While speaker after speaker preached against the legalization of marijuana, leading financial sponsors of the program included Purdue Pharma, the manufacturer of Oxycontin.As reported in The Nation, both CADCA and the Partnership for Drug-Free Kids (formerly the Partnership for a Drug-Free America) accept financial support from the producers of the same opioid medications that have led to tens of thousands of deaths. The same two groups, among others, have opposed U.S. Congressional efforts to label prescription opioids for “severe pain,” but they have supported continuing Medicare reimbursement for the addictive pills.Moreover, pharmaceutical companies take shelter in the DEA’s listing of marijuana as a Schedule 1 drug, the same category as heroin. As long as the DEA effectively prohibits marijuana medical research, Big Pharma can take the moral high road. The Schedule 1 designation severely limits needed research into the medical efficacy of cannabis-derivatives.”Big pharma is lobbying against legalization, on the purported grounds of safety, but in reality, they are just buying time to create their own synthetic cannabis medicines,” said Alan Hirsch, CEO of Diagnostic Lab Corporation, a cannabis safety and science company. “Several biotech companies have started creating cannabinoid chemistry from rice or yeast, but eventually, these medicines will be manufactured by Big Pharma in Schedule 1 facilities.” Big Pharma Is Developing Cannabis Painkillers – Here’s What They Can Do To Become Part of the Mainstream Market. https://t.co/WGj1yWE2rv pic.twitter.com/s0w3fmzsPe— HIGH TIMES (@HIGH_TIMES_Mag) July 19, 2017 The problem that started with the Trump campaign.Many of the same voters who elected President Donald J. Trump voted to liberalize marijuana enforcement. And, like everything else with the arrival of the Trump administration, things remain in a state of confusion pending official updated stance.In a Town Hall (03/20/2016) meeting, then-candidate Trump said, “I think that as far as drug legalization we talk about marijuana and in terms of medical I think I am basically for that. I’ve heard some wonderful things in terms of medical. I’m watching Colorado very carefully to see what’s happening out there.”Related: Getting Healthy, Not High: Using Cannabis to Fight CancerOn The O’Reilly Factor (02/12/2016), when Fox News’ Bill O’Reilly called medical marijuana a “ruse,” candidate Trump said, “But I know people that have serious problems and they did that they really — it really does help them.”Later, candidate Trump told the Washington Post (10/29/2016), “In terms of marijuana and legalization, I think that should be a state issue, state-by-state … Marijuana is such a big thing. I think medical should happen — right? Don’t we agree? I think so. And then I really believe we should leave it up to the states.”Decades ago he also told the Miami Herald (04/14/1990) “We’re losing badly the War on Drugs. You have to legalize drugs to win that war. You have to take the profit away from these drug czars.”Confusion about the Trump Administration and cannabis.President Donald J. Trump has sent several confusing signals to the pharmaceutical industry and the cannabis advocates. NewsMaxFinance (03/03/3017) quoted President-elect Trump as saying, “pharmaceutical companies are ‘getting away with murder’ in what they charge the government for medicines.” President Trump repeated that charge at a press conference reported by the Washington Post (01/11/2017) when he also said, “Pharma has a lot of lobbies, a lot of lobbyists and a lot of power.”Fox Business (02/01/2017) interviewed Eli Lilly’s CEO David A. Ricks following Trump’s White House meeting with pharmaceutical industry leaders. “When asked if he gave the president any commitment to reducing drug prices or to investing in U.S. operations or jobs, Ricks responded, ‘No, Lilly didn’t do that. But, what we did say is that with the right policy environment, in particular, the corporate tax rate which today is an inhibitor for us to invest in manufacturing here in the United States, along with other pro-business policies could allow us to expand operations in the U.S’.”Related: Will the ‘Entrepreneur’ President Embrace the Cannabis Economy?And, Emma Court of MarketWatch (03/01/2017) reported following Trump’s first State of the Union Address, “The Tuesday evening mention of drug prices underscores ‘our view that Trump is committed to some action to permit federal government involvement in pricing under Medicare Part D, his position for a year,’ Evercore ISI policy analyst Terry Haines said. ‘We continue to think that comes during ACA reform legislation when Trump can insist something be included as a condition of him signing the bill into law.’”So perhaps President Trump is jawboning the pharmaceutical industry to make a deal? Trump wants some concession he can take to his populist constituency in trade for lower corporate taxes. On the surface, this has nothing to do with marijuana. In fact, his position on marijuana may be something he can trade.Related: Marijuana Advocates Wait for Trump’s Stance on Legalized CannabisIt’s all about the money.Is Big Pharma for or against legalizing marijuana? Nothing shows that they favor accessibility to marijuana, and everything points to their opposition. However, investors in Big Pharmacy see the light. They remain in the market and are buying up. They see that there’s no moral high road here but there is money for Big Pharma in cannabis.“No pharmacy company is interested in making cheaper medicine,” Brian Chaplin, founder of Medicine Box told me in a written interview. “The existing Pharma industry is more about patenting and manufacturing medicine that is a treatment plan – not a curative plan.”Chaplin argues that Big Pharma wants customers to need their products, preferably for the rest of their lives, while creating “customers” but not healing specific ailments.“This is different from a ‘whole plant’ medicine approach — where we see patients responding to the synergistic effects of multiple compounds (cannabanoids and terpenes) in the plant that are usually lacking in a pharmacy — chemically prepared product,” he continued. Interestingly, Big Pharma playing in the fields of cannabis might, in fact, help declassify the plant. Christopher Teague of HERB writes, “Big Pharma will prove that cannabis is medicine a hundred times over, in every way, and the DEA will have to reclassify the plant itself.”According to Matt Gray, CEO and founder of HERB, “Big Pharma has already dipped its toe into cannabis treatment, with the DEA approving synthetic cannabis for pharma company, Insys.”That same company, however, also donated money to prevent cannabis legalization from occurring in Arizona. “This just proves the point that Big Pharma cares more about their bottom line than the actual treatment of patients,” he continued. “So if they find it financially beneficial, they will get involved in the industry, even if it isn’t necessarily for the right reasons.”In the end, it’s all about striking a winning balance. Trump needs a victory over high drug prices, especially as they affect Medicare Part D. Big Pharma is in a position to demand concessions. Accessibility to cannabis R&D might just be one of them. Pharmaceutical companies are intrigued by the immense and growing medical marijuana market but cannot figure a way to corner it. Cannabis August 8, 2017 –shares Opinions expressed by Entrepreneur contributors are their own. Is Big Pharma for or Against Legalizing Medical Marijuana? Maybe Both. Subscribe Now
Social Media Reporter Next Article Guest Writer Michael Kan Free Webinar | July 31: Secrets to Running a Successful Family Business 2 min read Image credit: JaysonPhotography / Shutterstock.com Learn how to successfully navigate family business dynamics and build businesses that excel. Russian efforts to influence American society over social media may have reached more than half of the country’s voting population, according to new findings that’ll be presented to Congress today.Facebook, for instance, has found that 126 million users in the country may have been exposed to 80,000 divisive political posts written by a Kremlin-back Russian company, according to The New York Times.Twitter uncovered over 36,000 accounts possibly linked with Russia that generated 1.4 million automated election-related tweets, according to a source familiar with its upcoming testimony. Those tweets received 288 million impressions.Google, on the other hand, found 1,108 videos on YouTube probably associated with a suspected Russian campaign to spread propaganda. The videos attracted 309,000 views in the U.S.More details will be presented during today’s congressional hearing on Russian interference in last year’s election. Representatives from all three U.S. tech companies are set to testify.Facebook will reportedly disclose that a Russian company called the Internet Research Agency controlled 470 accounts to publish the 80,000 posts. Those posts were served directly to 29 million users, and then liked, shared or followed by others, magnifying their spread.Russia’s Internet Research Agency, which is notorious for being an Internet troll farm, also spent $100,000 to display 3,000 ads on the platform with divisive political and social messages, Facebook claimed last month.Twitter also tracked over 2,700 users accounts to the Russian company, up from the 201 accounts it initially reported last month. All the accounts have been suspended. In addition, Twitter identified over 36,000 accounts found generating automated election-related content that possessed “at least one characteristic” associated with Russian user accounts.Although the accounts produced 1.4 million tweets, that only represented 0.74 percent of overall election-related tweets during the Sept. 1 to Nov. 15 time period, according to Twitter’s upcoming testimony.Despite Facebook’s and Twitter’s attempts to crack down on the abuse, U.S. lawmakers remain concerned that foreign governments will try to spread propaganda over their platforms in future elections. That may put Silicon Valley and Washington at odds over attempts to regulate social media.However, both Facebook and Twitter are taking steps to add more transparency to their online political ad business, including who buys what. Last week, Twitter banned two Russian media groups from advertising on the platform over concerns they were spreading Kremlin-back propaganda. Facebook, Google and Twitter are set to testify before a congressional subcommittee on Russia’s attempt to use social media to influence last year’s election. Facebook Says 126 Million Users May Have Been Exposed to Russian Posts –shares October 31, 2017 Add to Queue This story originally appeared on PCMag Register Now »
Add to Queue –shares Be inclusive, be respectful, and beware of the after party. Holidays December 11, 2017 Guest Writer Image credit: Ulrik Tofte | Getty Images Jonathan Segal Partner in Employment Practice Group of Duane Morris 8 Ways to Increase Holiday Cheers and Minimize January Jeers Next Article Apply Now » Opinions expressed by Entrepreneur contributors are their own. The holiday season can be the most wonderful time of the year, but it also poses legal and employee relations challenges to employers of all sizes. Most of these challenges can be mitigated with some thoughtful planning. So, here’s a checklist of some of the more salient issues to consider to minimize the risk that your December celebrations will result in January claims.1. Don’t eliminate Christmas.Don’t eliminate Christmas from the holiday season, says this Jewish guy. It’s a beautiful holiday that should be celebrated. And, a Christmas tree is just fine, too! Remember, it’s about inclusion, not exclusion. So, speaking of inclusion — what about those who don’t celebrate Christmas?Related: 6 Strategic Ways to Prepare Your Small Business for the Festive Season2. Include other holidays.Recognize other holidays, such as Hanukkah and Kwanza, in your decorations and announcements. For example, consider a menorah and Kwanza basket along with the Christmas tree. 3. What holiday did you forget?You don’t know what you don’t know. Profound, no? So, ask. Ask employees if there is a holiday that they would like to see included in the celebration (and that includes decorations). Reminder: the Buddhist holiday of Bodhi day falls on January 5 this year. 4. What should you call your party?“Holiday party” or “Celebration of the Season” are inclusive terms. Make the party itself inclusive too by having decorations and the music reflect diverse holidays. But which decorations and songs? Those that are more religious are more appropriate for religious celebrations (or for religious employers). Fact: Springsteen’s “Santa Claus is Coming to Town” is just fine!Related: 4 Ways to Prepare Your Marketing for the Upcoming Holiday Season5. Should you serve alcohol?Never serve it to minors. Make clear adults who get it for them will be subject to immediate discharge. As for adults, take steps to minimize abuse, such as limiting drinks, providing lots of food or even making employees pay for alcohol and then donating the money, with a match, to charity.Even with restrictions, assume some people may abuse the alcohol you serve. Consider having cab vouchers ready for them without management knowing who the users are. This increases the likelihood that those who need vouchers will use them.6. What about harassment?This is perennial problem at holiday parties. But you can bet this year employees who are subject to improper conduct appropriately will speak up. #MeToo. Remind your employees that your anti-harassment policy applies to the party. But that’s not enough. Make sure to remind managers of their responsibilities. If you are in management and you see or hear unacceptable comments or conduct, you must intervene. To see and ignore is to condone.7. What about the “after party?”To be blunt, no good comes from after parties. Unless, you consider claims arising out of the after party good. Make clear you are not sponsoring any after party, and do not allow employer money to be used for it. And, never attend if you are in management. Attending is about as safe as walking on railroad tracks.Related: Don’t Commit These 7 Party Fouls Inspired by ‘Office Christmas Party’8. What about greetings?It’s best to be general with your holiday greetings unless you know otherwise. The default should be “Happy Holidays.” But if you know someone is Christian, by all means wish that person a Merry Christmas. I do, and I appreciate it when people wish me a “Happy Hanukkah” because they know I am Jewish. I am less thrilled if they are making assumptions. When addressing groups, be as inclusive as you can be, as I shall try to do now: If you celebrate Christmas, Hanukkah or Kwanzaa, I wish you a peaceful and meaningful holiday that corresponds with your faith. If you observe another holiday now, I apologize for not referencing it by name, but I give you my good wishes just the same, as I do for those who recognize no holidays or who celebrate at another time of year. May peace be with all! And, please, be good to each other. 4 min read The only list that measures privately-held company performance across multiple dimensions—not just revenue. 2019 Entrepreneur 360 List
Add to Queue March 19, 2018 Apple Is Reportedly Trying to Make its Own Displays Next Article –shares 2 min read Matthew Humphries Image credit: via PC Mag Senior Editor Apple’s laptops, smartphones, tablets and watches rely on hundreds of parts, most of which Apple sources from other companies around the world. But the more of those parts Apple can make itself, the more profit it can generate as well as making its supply chain more reliable. Apple already started making its own chips, now it’s attempting to make displays.As Bloomberg reports, Apple is thought to be designing and producing its own displays in a secret manufacturing facility near California. More specifically, the focus is on producing MicroLED screens like those recently produced by Samsung to form the 146-inch modular TV launching in August.In Apple’s case, perfecting MicroLED screen production would remove the need to rely on companies including Samsung, Japan Display, Sharp, and LG Display. We could see Apple displays used in the Apple Watch ($329.00 at Best Buy), iPhone, iPad and maybe even MacBooks ($1,249.00 at Amazon) in the future, but there’s one big problem: MicroLED is extremely difficult to manufacture.Apple’s focus on MicroLED is due to the benefits offered, notably they create thinner, brighter and less power-hungry displays without the downsides of OLED (limited life span, brightness). However, because each pixel has its own light in a MicroLED array, it throws up some manufacturing challenges. Those challenges apparently almost made Apple shut down the project last year, but it didn’t, and now working displays are being produced.It’s unlikely we’ll see these Apple displays any time soon, if at all. The cost of mass producing OLED and eventually MicroLED will continue to fall and other manufacturers already focused on display production will benefit first. Apple would need to invest heavily in facilities before it could get serious about making displays. So, for the foreseeable future, expect Apple to continue signing display contracts with its partners. Free Webinar | July 31: Secrets to Running a Successful Family Business This story originally appeared on PCMag Apple If successful, Apple will no longer have to rely on another company for its screens. Learn how to successfully navigate family business dynamics and build businesses that excel. Register Now »
Lindsay Friedman Are You in the Top 50 Percent of Earners in Your City? — Start Up Your Day Roundup Next Article Staff writer. Frequently covers franchise news and food trends. Register Now » 2 min read Free Webinar | July 31: Secrets to Running a Successful Family Business Opinions expressed by Entrepreneur contributors are their own. Add to Queue March 10, 2016 Learn how to successfully navigate family business dynamics and build businesses that excel. Start Up Your Day Image credit: Shutterstock Everyone can give you the headlines. We help you learn from the day’s shifts, both big and small. McDonald’s opens in Borat’s home country. The Big Mac comes to Kazakhstan, according to the New York Post. The fast food franchise opened its first location in the country on Tuesday.The tipping point. Looking at the amount of money it takes to make it into the top 1 or 10 percent of earners can be downright dispiriting. But cracking the top 50 percent? That’s not as discouraging! In New York City, for example, if you make $52,000 a year you’re earning more than 50 percent of residents, according to Business Insider.Just like in the movies. Goodyear unveiled spherical tires, similar to the ones seen in the Will Smith movie I, Robot, at the Geneva International Motor Show. While the tires are still a concept, they’re pretty cool to look at. Venture Beat has more.Watch a Google smart car hit a bus. The very slow, very anti-climactic video is finally out and ready for you to see.Lost and out of network on the road? Try out this new GPS application, which stores maps on your smartphone for offline use. It now covers the entire globe, save for a couple of volcanic islands and Antarctica. –shares
We are world-leaders across a range of science and research disciplines, and the SIAs published today show the whole nation contributes to that reputation.We are committed to building on these strengths and others in our modern Industrial Strategy through the largest increase in science funding in a generation.” The North of England is a powerhouse in health research and it is excellent to see this recognised today by Government through the publication of the NHSA’s NPiHR SIA.The North’s world-leading strengths in using data for better health and wealth, in precision medicine, and in nurturing health innovation talent, are among many other attributes in health science recognised in this document.Through using the considerable assets and collateral mapped out in the SIA, Government has the potential to drive the North’s economy forward and to rebalance the whole country as an economic powerhouse for the 21st century.” By working with place-based communities, supported by initiatives such as #Datasaveslives and Connected Health Cities (CHC), and pioneering assets such as the Great North and Leeds Care Records and the Salford Lung Study, the North is in prime position to diffuse and embed digitally-enabled Precision Medicine research and application at scale, for the benefit of UK citizens and the national economy.” Mar 11 2019Today, the Government has announced the publication of the Northern Health Science Alliance’s (NHSA) Northern Powerhouse in Health Research (NPiHR) Science and Innovation Audit (SIA). Source:http://www.thenhsa.co.uk/2019/03/nhsa-sia-reveals-potential-to-close-north-south-productivity-gap/ The NHSA’s ambition is to use the SIA as a way to help the North become a healthier and more economically productive place in which to live, narrowing the North’s health, wealth, and productivity gaps compared with the South of England.Nicola Wilson, Interim CEO of the NHSA, said: Related StoriesResearch sheds light on sun-induced DNA damage and repairComplement system shown to remove dead cells in retinitis pigmentosa, contradicting previous researchAXT enhances cellular research product portfolio with solutions from StemBioSysThe footprint of the (NPiHR) area is formed by eight cities and their hinterlands: Durham, Lancaster, Leeds, Liverpool, Manchester, Newcastle, Sheffield, and York. The research-intensive universities in each of these cities form the N8 Research Partnership.The Life Science businesses in the North work collectively through the membership organisation Bionow. Four Academic Health Science Networks (AHSNs) and 11 Local Enterprise Partnerships (LEPs) operate in the SIA’s geography. And the Northern Health Science Alliance (NHSA) works on a pan-Northern basis with these organisations and networks.The Northern Powerhouse is home to 21% of the total UK life science sector workforce, and has grown by more than 9% to over 50,000 employees since 2012. Latest figures for 2017 show the value of this sector in the North to be over £13.6 billion.Ms Wilson continued: The NPiHR SIA highlights the region’s ability to drive clinical research across its 16 million population by drawing on the region’s expertise in health and life sciences.It follows on from the Industrial Strategy Life Sciences Sector Deal published in December which revealed £1.6bn of planned industry investment in the North’s life sciences over the next five years.In November 2018 the NHSA’s “Health for Wealth” report demonstrated £1.20 of the £4 per person productivity gap between the North and South of England was directly attributable to poorer health in the North.Universities and Science Minister Chris Skidmore said:
Uber is fighting to keep its licence in London This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Explore further US ride-hailing app Uber on Friday announced new safety features for its service in Britain, as it appeals against the withdrawal of its licence in London. Citation: Uber introduces UK safety measures amid licence battle (2018, February 16) retrieved 18 July 2019 from https://phys.org/news/2018-02-uber-uk-safety-licence.html © 2018 AFP Uber’s London licence battle set for May/June The service, which has around 40,000 drivers in London, lost its licence over its reporting of serious criminal offences and its criminal-record checks for drivers, but is allowed to operate in the capital pending the appeal which is set to be heard later this year.Uber will now “pro-actively” make reports of serious incidents related to a trip to the police, rather than encouraging individuals to contact authorities themselves, according to a statement on its website.From next month, passengers will also receive the driver’s licence number in their booking confirmation, meaning passengers can more easily raise issues with the relevant licensing authority.The app has already capped the number of hours its drivers can work in Britain in a bid to increase safety after heavy criticism of its business practices, and will set up a 24/7 telephone helpline for riders and drivers.”We’re determined to change the way we do business, so we’ll carry on listening and plan to make other improvements over the coming months,” it said.London’s transport authority said in September that it would not renew the ride-hailing company’s licence, with the appeal due to be heard in May or June.
Tumblr will begin enforcing its ban on adult content on December 17, 2018, giving users who host unwanted explicit content an opportunity to take their imagery elsewhere, according to chief executive Jeff D’Onofrio Explore further Tumblr will begin enforcing its new policy on December 17, giving users who host unwanted explicit content an opportunity to take their imagery elsewhere, according to chief executive Jeff D’Onofrio.”There are no shortage of sites on the internet that feature adult content,” D’Onofrio said in a blog post.”We will leave it to them and focus our efforts on creating the most welcoming environment possible for our community.”The decision to purge porn from Tumblr was made after “serious thought” regarding standards in the blogging community, according to the chief executive.”Posts that contain adult content will no longer be allowed on Tumblr, and we’ve updated our Community Guidelines to reflect this policy change,” D’Onofrio said.He maintained that Tumblr will strive to balance allowing conversation about topics such as sex and relationships with banning porn, and noted there are likely to be stumbles.Child porn was already against Tumblr guidelines.”Posting anything that is harmful to minors, including child pornography, is abhorrent and has no place in our community,” D’Onofrio said.”We’ve always had and always will have a zero tolerance policy for this type of content.”Tumblr’s applications for Apple devices were shut out of the App Store last month after child sexual abuse material was found on the platform.Tumblr uses an industry database to filter content being uploaded, but child porn material that had not yet been added to the database made it onto the platform, the company said.The offending content was removed as soon as it was discovered in a routine audit, according to Tumblr.D’Onofrio took over as chief of Tumblr from founder David Karp late last year.Karp’s departure from the company came a few months after Verizon bought parent-company Yahoo in a $4.5 billion deal.Karp founded Tumblr in New York in early 2007 as a platform where people could share writing and short-form media. Now, Tumblr hosts some 417 million different blogs.Yahoo acquired Tumblr in May 2013 for $1.1 billion, as part of an effort to better connect with younger online users. Discovery of child pornography leads to Tumblr’s removal from Apple’s App Store © 2018 AFP Tumblr on Monday said it is banning adult content from the Yahoo-owned blogging platform, which saw its app pulled from Apple’s App Store last month over child pornography. This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. Citation: Tumblr bans porn to clean up the blogging platform (2018, December 3) retrieved 17 July 2019 from https://phys.org/news/2018-12-tumblr-porn-blogging-platform.html
Explore further The world’s largest paid online TV network is raising prices by 13 percent to 18 percent, which is the 12-year-old company’s biggest price hike ever. Its most popular monthly service plan will rise to $12.99 from $10.99. The cheapest plan will increase to $8.99 from $7.99, and the premium plan will rise to $15.99 from $13.99.The price increase could have an effect on adding new U.S. subscribers going forward, according to Wedbush Securities analyst Michael Pachter.”We do not expect significant churn given the utility provided by the service to existing subscribers, but attracting new subscribers will likely be more challenging because of the higher prices,” Pachter said.”We change pricing from time to time as we continue investing in great entertainment and improving the overall Netflix experience for the benefit of our members,” a Netflix spokesperson said in a statement to USA TODAY.As the streaming giant pushes to rely on its TV and film studios to make more of its own content, rather than licensing content, viewers can expect to see new seasons of hit shows like Making a Murderer, House of Cards, The Crown, and Stranger Things.Some of the streamer’s major investments in talent and programming will hit screens small and big in 2019, including series The Umbrella Academy, and Martin Scorsese’s crime drama, The Irishman.The earnings report comes amid growing competition in the streaming space in 2019. AT&T, now the owners of Time Warner’s vast content library (including HBO), plans to launch a streaming offering later this year. As does Disney, which is in the process of acquiring 21st Century Fox’s movie and TV studios.In the company’s earnings interview, Netflix made a surprising move, revealing some of its viewership data.In the wildly popular interactive movie Black Mirror: Bandersnatch, the first choice in the story was a breakfast cereal: Frosties or Sugar Puffs? Netflix revealed that 73 percent of people chose Frosties.Netflix’s Chief Product Officer Greg Peters said that viewers can expect to see more interactive entertainment in the future.”There have been a few false starts on interactive storytelling in the last couple (of) decades. This one has storytellers salivating about the possibilities,” said Netflix’s Chief Content Officer Ted Sarandos. “We’ve got a hunch that it works across all kinds of storytelling. Some of the greatest storytellers in the world are excited to dig into it.”Netflix also said that 80 million member households have watched its thriller starring the actress Sandra Bullock, Bird Box, in its first four weeks.Overall, Netflix said it serves about 100 million hours of video per day, earning an estimated 10 percent of all time spent in front of the TV in the U.S.”One thing this quarter that’s been incredibly exciting is when you see a big number like Bird Box and You,” Sarandos said during Netflix’s earnings interview. “These shows are playing incredibly globally. So it’s an interesting thing when you can tap into the global zeitgeist with something, which gets me very excited about the potential scale of the content business when the world is excited about something.”The Los Gatos, California-based company reported earnings of 30 cents a share, beating analyst estimates of 24 cents a share.Netflix reported net income of $133.9 million, or 30 cents a share, on sales of $4.19 billion. (c)2019 USA TodayDistributed by Tribune Content Agency, LLC. “We compete with (and lose to) Fortnite more than HBO,” Netflix said in a letter to shareholders Thursday as the company reported its quarterly earnings. “There are thousands of competitors in this highly fragmented market vying to entertain consumers.”On the heels of a celebratory third quarter, Netflix’s latest earnings report was met with mixed reviews.Though the streaming giant’s subscription growth beat analyst expectations—Netflix reported 8.8 million new additions compared to the 7.5 million new subscribers that analysts projected—the video streaming company’s shares fell about 3 percent in after-hours trading.Netflix’s global paid subscriber additions also topped its own forecast of 7.6 million.”The fact that investors reacted negatively to what amounted to a strong performance indicates the extent to which Netflix has set a high bar,” said eMarketer media analyst Paul Verna. “The bottom line is that Netflix remains the uncontested leader in the subscription video space.”Thursday’s announcement comes just two days after the streaming media titan flexed its pricing power, phasing in a U.S. subscription price hike over the next three months for existing subscribers. The new prices will become effective immediately for new subscribers.The company reported a total of 393.3 million members worldwide.During the same October-December period last year, Netflix added 6.6 million paying subscribers and 8.3 million total subscribers.The company is projecting it will add 8.9 million new paid customers during the first quarter, which is lower than analysts projected. Netflix expects earnings per share of 56 cents with revenue of $4.49 billion, compared with analyst estimates of 83 cents and $4.61 billion in revenue.Netflix announces only guidance on paid membership subscriptions, rather than the total number of memberships which includes people who may be using a free trial. It said in October that it will stop including end-of-quarter free trial subscriber numbers in its reports. Netflix shares slip as spending weighs on profits Even though every other media company seems to be starting a streaming service, Netflix is facing an on-screen challenge from another corner: “Fortnite,” that ultra-popular, multiplatform videogame, appears to be a formidable foe. Citation: Netflix is in a battle royale with Fortnite in the fight for your screen time (2019, January 21) retrieved 17 July 2019 from https://phys.org/news/2019-01-netflix-royale-fortnite-screen.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Cauvery Water SHARE SHARE EMAIL December 10, 2018 Published on rivers COMMENT The Tamil Nadu government on Monday said Karnataka’s request for talks on the Mekedatu issue “is an attempt to impede” proceedings in the Supreme Court and asked it not to go ahead with the DPR on the project and also any other construction in the Cauvery river basin without its nod.Law Minister C Ve Shanmugham was responding to Karnataka Water Resources Minister DK Shivakumar, who had last week written to Tamil Nadu Chief Minister K Palaniswami seeking an appointment with him to discuss the proposed project and reach an amicable solution.Shivakumar had said the project will help in regulating judicious release of water so that excess water is not allowed to flow from the Mettur dam in Salem in Tamil Nadu into the sea needlessly as has had happened this year. He had wanted to discuss with Palaniswami, the “misconceptions” over his State’s proposal for a dam. SHARE COMMENTS